Prudential Financial Inc. grew its position in shares of Humana Inc (NYSE:HUM) by 53.6% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 378,133 shares of the insurance provider’s stock after purchasing an additional 131,990 shares during the quarter. Prudential Financial Inc. owned 0.26% of Humana worth $92,125,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. boosted its position in Humana by 1.6% during the second quarter. Vanguard Group Inc. now owns 9,892,635 shares of the insurance provider’s stock valued at $2,380,366,000 after purchasing an additional 157,868 shares during the last quarter. FMR LLC boosted its position in Humana by 29.3% during the second quarter. FMR LLC now owns 6,530,063 shares of the insurance provider’s stock valued at $1,571,264,000 after purchasing an additional 1,479,210 shares during the last quarter. Capital Research Global Investors boosted its position in Humana by 9.7% during the second quarter. Capital Research Global Investors now owns 3,907,333 shares of the insurance provider’s stock valued at $940,182,000 after purchasing an additional 346,069 shares during the last quarter. Renaissance Technologies LLC raised its holdings in Humana by 1.5% during the second quarter. Renaissance Technologies LLC now owns 2,731,100 shares of the insurance provider’s stock valued at $657,157,000 after buying an additional 39,400 shares in the last quarter. Finally, Janus Henderson Group PLC raised its holdings in Humana by 74.1% during the third quarter. Janus Henderson Group PLC now owns 2,729,248 shares of the insurance provider’s stock valued at $664,921,000 after buying an additional 1,161,661 shares in the last quarter. Institutional investors and hedge funds own 94.01% of the company’s stock.
In other Humana news, SVP Jody L. Bilney sold 7,054 shares of the stock in a transaction dated Monday, December 18th. The shares were sold at an average price of $247.89, for a total value of $1,748,616.06. Following the transaction, the senior vice president now directly owns 11,704 shares of the company’s stock, valued at approximately $2,901,304.56. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, VP Timothy S. Huval sold 1,382 shares of the stock in a transaction dated Tuesday, December 19th. The shares were sold at an average price of $246.04, for a total transaction of $340,027.28. Following the completion of the transaction, the vice president now directly owns 11,557 shares in the company, valued at $2,843,484.28. The disclosure for this sale can be found here. Insiders sold a total of 10,115 shares of company stock valued at $2,501,627 over the last quarter. 0.80% of the stock is currently owned by company insiders.
HUM has been the topic of several recent research reports. Credit Suisse Group dropped their price objective on Humana from $256.00 to $246.00 and set a “neutral” rating on the stock in a research note on Friday, November 10th. ValuEngine lowered Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, October 10th. BMO Capital Markets boosted their price target on Humana from $290.00 to $300.00 and gave the company an “outperform” rating in a research note on Friday, November 10th. Jefferies Group reaffirmed a “hold” rating and set a $257.00 price objective on shares of Humana in a report on Friday, October 13th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $242.00 price objective (down from $245.00) on shares of Humana in a report on Thursday, November 9th. Eleven investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $260.70.
Humana Inc (NYSE HUM) opened at $263.10 on Thursday. Humana Inc has a one year low of $186.25 and a one year high of $264.90. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.61 and a quick ratio of 1.61. The firm has a market cap of $37,470.00, a price-to-earnings ratio of 20.72, a P/E/G ratio of 1.74 and a beta of 0.88.
Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, November 8th. The insurance provider reported $3.39 EPS for the quarter, topping the Zacks’ consensus estimate of $3.27 by $0.12. Humana had a net margin of 3.49% and a return on equity of 15.99%. The company had revenue of $13.28 billion during the quarter, compared to the consensus estimate of $13.41 billion. During the same period in the prior year, the business posted $3.18 EPS. The company’s quarterly revenue was down 3.0% on a year-over-year basis. analysts predict that Humana Inc will post 11.63 earnings per share for the current year.
Humana declared that its Board of Directors has approved a stock buyback program on Thursday, December 14th that allows the company to buyback $3.00 billion in outstanding shares. This buyback authorization allows the insurance provider to purchase shares of its stock through open market purchases. Shares buyback programs are typically a sign that the company’s management believes its shares are undervalued.
The company also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, December 29th will be paid a $0.40 dividend. The ex-dividend date is Thursday, December 28th. This represents a $1.60 annualized dividend and a yield of 0.61%. Humana’s dividend payout ratio (DPR) is currently 12.60%.
TRADEMARK VIOLATION NOTICE: “Humana Inc (HUM) Shares Bought by Prudential Financial Inc.” was originally reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this article on another site, it was illegally copied and republished in violation of US and international copyright and trademark law. The correct version of this article can be viewed at https://ledgergazette.com/2018/01/11/prudential-financial-inc-has-92-13-million-holdings-in-humana-inc-hum.html.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.